2.150USD-3.80%Mkt Cap: 22.92M USDP/E: —Last update: 2026-06-01
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hype…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap22.92M USD
Enterprise Value19.68M USD
Revenue (TTM)56.60M USD
Gross Profit45.83M USD
Net Income (TTM)-13.56M USD
Revenue/Share6.158 USD
Last Price2.150 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees82
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS0547548588
Valuation
P/E (Trailing)—
P/E (Forward)-45.80
PEG—
EV/EBITDA-7.50
EV/Revenue0.35
P/S0.43
P/B0.70
EPS (TTM)-4.61
EPS (Forward)-0.05
52W Range
1.46043% of range3.070
52W High3.070 USD
52W Low1.460 USD
Profitability
Gross Margin69.04%
Oper. Margin-32.74%
EBITDA Margin-4.64%
Profit Margin-20.43%
ROE-71.51%
ROA-10.92%
Growth
Revenue Growth-32.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.94M USD
CapEx (TTM)3.23M USD
FCF Margin-1.90%
FCF Yield-4.68%
Net Debt-4.90M USD
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity1.15
Current Ratio1.12
Quick Ratio0.85
Book Value/Sh3.274 USD
Cash/Share2.489 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 9, 2020
Splits
Last Split1:20
Split DateJan 6, 2023
Analyst Consensus
Rating—
Target (Mean)9.333 USD
Target Range7.000 USD – 14.00 USD
# Analysts3
Ownership
Shares Out.10.73M
Float7.61M
Insiders8.98%
Institutions36.58%
Short Interest
Short Ratio10.3d
Short % Float4.97%
Short % Out.4.27%
Shares Short457.79K
Short (prev mo.)502.21K
Technical
SMA 502.492 (-13.7%)
SMA 2002.380 (-9.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)45.96K
Avg Vol (10d)52.49K
Technical Indicators
RSI (14)42.3
MACD-0.0941
MACD Signal-0.0984
MACD Hist.+0.0043
BB Upper2.663 USD
BB Middle2.308 USD
BB Lower1.952 USD
BB Width30.81%
ATR (14)0.1048 USD
Vol Ratio (20d)0.45x